相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Regulation of motor proteins, axonal transport deficits and adult-onset neurodegenerative diseases
Scott T. Brady et al.
NEUROBIOLOGY OF DISEASE (2017)
Neurodegenerative signaling factors and mechanisms in Parkinson's pathology
Poonam Goswami et al.
TOXICOLOGY IN VITRO (2017)
Modulation of Microglial Activity by Rho-Kinase (ROCK) Inhibition as Therapeutic Strategy in Parkinson's Disease and Amyotrophic Lateral Sclerosis
Anna-Elisa Roser et al.
FRONTIERS IN AGING NEUROSCIENCE (2017)
Increased Levels of Pro-Inflammatory and Anti-Inflammatory Cellular Responses in Parkinson's Disease Patients: Search for a Disease Indicator
Likun Yang et al.
MEDICAL SCIENCE MONITOR (2017)
PINK1/Parkin-Dependent Mitochondrial Surveillance: From Pleiotropy to Parkinson's Disease
Francois Mouton-Ligeri et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)
A novel pleiotropic effect of aspirin: Beneficial regulation of pro- and antiinflammatory mechanisms in microglial cells
Diana Kata et al.
BRAIN RESEARCH BULLETIN (2017)
Emerging (and converging) pathways in Parkinson's disease: keeping mitochondrial wellness
Domenico Cieri et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Are Dopamine Oxidation Metabolites Involved in the Loss of Dopaminergic Neurons in the Nigrostriatal System in Parkinson's Disease?
Andrea Herrera et al.
ACS CHEMICAL NEUROSCIENCE (2017)
LRRK2 in peripheral and central nervous system innate immunity: its link to Parkinson's disease
Heyne Lee et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2017)
Dopamine and T cells: dopamine receptors and potent effects on T cells, dopamine production in T cells, and abnormalities in the dopaminergic system in T cells in autoimmune, neurological and psychiatric diseases
M. Levite
ACTA PHYSIOLOGICA (2016)
Current disease modifying approaches to treat Parkinson's disease
Dan Lindholm et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2016)
Inhibition of Rho-kinase by Fasudil protects dopamine neurons and attenuates inflammatory response in an intranasal lipopolysaccharide-mediated Parkinson's model
Qing He et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2016)
Fasudil, a Rho kinase inhibitor, promotes the autophagic degradation of A53T α-synuclein by activating the JNK 1/Bcl-2/beclin 1 pathway
Feng-Tao Liu et al.
BRAIN RESEARCH (2016)
Neutralization of RANTES and Eotaxin Prevents the Loss of Dopaminergic Neurons in a Mouse Model of Parkinson Disease
Goutam Chandra et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Anti-Inflammatory Modulation of Microglia via CD163-Targeted Glucocorticoids Protects Dopaminergic Neurons in the 6-OHDA Parkinson's Disease Model
Noemie Tentillier et al.
JOURNAL OF NEUROSCIENCE (2016)
Oxidative stress: A major pathogenesis and potential therapeutic target of antioxidative agents in Parkinson's disease and Alzheimer's disease
Tianfang Jiang et al.
PROGRESS IN NEUROBIOLOGY (2016)
Removal of regulatory T cells prevents secondary chronic infection but increases the mortality of subsequent sub-acute infection in sepsis mice
Ruichao Huo et al.
ONCOTARGET (2016)
CD200 Inhibits Inflammatory Response by Promoting KATP Channel Opening in Microglia Cells in Parkinson's Disease
Yi Ren et al.
MEDICAL SCIENCE MONITOR (2016)
The role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?
Kevin R. Doty et al.
BRAIN RESEARCH (2015)
The Role of Neuroinflammation in Dementias
Giuseppe Pasqualetti et al.
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2015)
Antagonistic pleiotropic effects of nitric oxide in the pathophysiology of Parkinson's disease
D. Tripathy et al.
FREE RADICAL RESEARCH (2015)
Immunomodulatory and neuroprotective effects of ginsenoside Rg1 in the MPTP(1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) -induced mouse model of Parkinson's disease
Ting-ting Zhou et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2015)
Striatal blood-brain barrier permeability in Parkinson's disease
Madison T. Gray et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2015)
Neuroprotective effect of water extract of Panax ginseng on corticosterone-induced apoptosis in PC12 cells and its underlying molecule mechanisms
Yumao Jiang et al.
JOURNAL OF ETHNOPHARMACOLOGY (2015)
A Perspective on Roles Played by Innate and Adaptive Immunity in the Pathobiology of Neurodegenerative Disorders
Howard E. Gendelman et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2015)
Efficacy and safety profile of prolonged release oxycodone in combination with naloxone (OXN PR) in Parkinson's disease patients with chronic pain
Graziella Madeo et al.
JOURNAL OF NEUROLOGY (2015)
Multitarget intervention of Fasudil in the neuroprotection of dopaminergic neurons in MPTP-mouse model of Parkinson's disease
Yong-fei Zhao et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)
The role of quercetin on the survival of neuron-like PC12 cells and the expression of α-synuclein
Tae-Beom Ahn et al.
NEURAL REGENERATION RESEARCH (2015)
THE RELATION BETWEEN α-SYNUCLEIN AND MICROGLIA IN PARKINSON'S DISEASE: RECENT DEVELOPMENTS
V. Sanchez-Guajardo et al.
NEUROSCIENCE (2015)
Low-dose aspirin (acetylsalicylate) prevents increases in brain PGE2, 15-epi-lipoxin A4 and 8-isoprostane concentrations in 9 month-old HIV-1 transgenic rats, a model for HIV-1 associated neurocognitive disorders
Helene C. Blanchard et al.
PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS (2015)
Revisiting the Mechanisms of CNS Immune Privilege
Antoine Louyeau et al.
TRENDS IN IMMUNOLOGY (2015)
Immune phenotypes of microglia in human neurodegenerative disease: challenges to detecting microglial polarization in human brains
Douglas G. Walker et al.
ALZHEIMERS RESEARCH & THERAPY (2015)
Neuroinflammation in Parkinson's disease and its potential as therapeutic target
Qinqin Wang et al.
TRANSLATIONAL NEURODEGENERATION (2015)
Rho Kinase and Dopaminergic Degeneration: A Promising Therapeutic Target for Parkinson's Disease
Jose L. Labandeira-Garcia et al.
NEUROSCIENTIST (2015)
Anti-apoptotic and Anti-oxidative Roles of Quercetin After Traumatic Brain Injury
Tao Yang et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2014)
Discovery of a benzofuran derivative (MBPTA) as a novel ROCK inhibitor that protects against MPP+-induced oxidative stress and cell death in SH-SY5Y cells
Cheong-Meng Chong et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
HSP60 is involved in the neuroprotective effects of naloxone
Wenjing Cheng et al.
MOLECULAR MEDICINE REPORTS (2014)
Renoprotective, anti-oxidative and anti-apoptotic effects of oral low-dose quercetin in the C57BL/6J model of diabetic nephropathy
Isabele B. S. Gomes et al.
LIPIDS IN HEALTH AND DISEASE (2014)
Inhibition of the microglial response is essential for the neuroprotective effects of Rho-kinase inhibitors on MPTP-induced dopaminergic cell death
Ana Borrajo et al.
NEUROPHARMACOLOGY (2014)
Potential neuroprotective effect of ibuprofen, insights from the mice model of Parkinson's disease
Maciej Świątkiewicz et al.
Pharmacological Reports (2014)
Astrocytic modulation of blood brain barrier: perspectives on parkinson's disease
Ricardo Cabezas et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2014)
Evidence of Inflammatory System Involvement in Parkinson's Disease
Yinxia Chao et al.
BIOMED RESEARCH INTERNATIONAL (2014)
The majority of newly generated cells in the adult mouse substantia nigra express low levels of ;Doublecortin, but their proliferation is unaffected by 6-;OHDA-induced nigral lesion or ;Minocycline-mediated inhibition of neuroinflammation
Maik M. A. Worlitzer et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2013)
Autoimmunity, dendritic cells and relevance for Parkinson's disease
E. Koutsilieri et al.
JOURNAL OF NEURAL TRANSMISSION (2013)
Immune Heterogeneity in Neuroinflammation: Dendritic Cells in the Brain
Carol A. Colton
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Parkinson's Disease and Alpha Synuclein: Is Parkinson's Disease a Prion-Like Disorder?
C. Warren Olanow et al.
MOVEMENT DISORDERS (2013)
Immune Privilege as an Intrinsic CNS Property: Astrocytes Protect the CNS against T-Cell-Mediated Neuroinflammation
Ulrike Gimsa et al.
MEDIATORS OF INFLAMMATION (2013)
Inhibition of Rho kinase mediates the neuroprotective effects of estrogen in the MPTP model of Parkinson's disease
Ana I. Rodriguez-Perez et al.
NEUROBIOLOGY OF DISEASE (2013)
QUERCETIN UP-REGULATES MITOCHONDRIAL COMPLEX-I ACTIVITY TO PROTECT AGAINST PROGRAMMED CELL DEATH IN ROTENONE MODEL OF PARKINSON'S DISEASE IN RATS
S. S. Karuppagounder et al.
NEUROSCIENCE (2013)
Enhanced Prostacyclin Synthesis by Adenoviral Gene Transfer Reduced Glial Activation and Ameliorated Dopaminergic Dysfunction in Hemiparkinsonian Rats
May-Jywan Tsai et al.
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2013)
Microglial Cells Are Involved in the Susceptibility of NADPH Oxidase Knockout Mice to 6-Hydroxy-Dopamine-Induced Neurodegeneration
Marina S. Hernandes et al.
PLOS ONE (2013)
Microglial Ion Channels as Potential Targets for Neuroprotection in Parkinson's Disease
Jason R. Richardson et al.
NEURAL PLASTICITY (2013)
Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's disease
Lars Toenges et al.
BRAIN (2012)
IGF-I receptor signaling pathway is involved in the neuroprotective effect of genistein in the neuroblastoma SK-N-SH cells
Quan-Gui Gao et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2012)
Redox regulation of protein misfolding, mitochondrial dysfunction, synaptic damage, and cell death in neurodegenerative diseases
Tomohiro Nakamura et al.
EXPERIMENTAL NEUROLOGY (2012)
Emerging analgesic drugs for Parkinson's disease
Santiago Perez-Lloret et al.
EXPERT OPINION ON EMERGING DRUGS (2012)
Anti-inflammatory, anti-proliferative and anti-atherosclerotic effects of quercetin in human in vitro and in vivo models
Robert Kleemann et al.
ATHEROSCLEROSIS (2011)
NSAID use and risk of Parkinson disease: a population-based case-control study
C. Becker et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
Impaired CD200-CD200R-mediated microglia silencing enhances midbrain dopaminergic neurodegeneration: Roles of aging, superoxide, NADPH oxidase, and p38 MAPK
Xi-Jin Wang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2011)
Astrocytes and Microglia: Responses to Neuropathological Conditions
Sarika Singh et al.
INTERNATIONAL JOURNAL OF NEUROSCIENCE (2011)
Antioxidant treatment with quercetin ameliorates erectile dysfunction in streptozotocin-induced diabetic rats
Wei Zhang et al.
JOURNAL OF BIOSCIENCE AND BIOENGINEERING (2011)
Flt3L controls the development of radiosensitive dendritic cells in the meninges and choroid plexus of the steady-state mouse brain
Niroshana Anandasabapathy et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
The acute inflammatory response to intranigral α-synuclein differs significantly from intranigral lipopolysaccharide and is exacerbated by peripheral inflammation
Yvonne Couch et al.
JOURNAL OF NEUROINFLAMMATION (2011)
Glia: Initiators and Progressors of Pathology in Parkinson's Disease
Glenda M. Halliday et al.
MOVEMENT DISORDERS (2011)
Role of glial cells in neurotoxin-induced animal models of Parkinson's disease
Hironori Yokoyama et al.
NEUROLOGICAL SCIENCES (2011)
Use of non-steroidal anti-inflammatory drugs and risk of Parkinson's disease: nested case-control study
Jane A. Driver et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Peripheral Inflammation Increases the Damage in Animal Models of Nigrostriatal Dopaminergic Neurodegeneration: Possible Implication in Parkinson's Disease Incidence
A. Machado et al.
PARKINSONS DISEASE (2011)
Parkinson's disease and immunological abnormalities: increase of HLA-DR expression on monocytes in cerebrospinal fluid and of CD45RO+ T cells in peripheral blood
U. Fiszer et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
An Association between Immunosenescence and CD4+CD25+ Regulatory T Cells: A Systematic Review
Ling Wang et al.
BIOMEDICAL AND ENVIRONMENTAL SCIENCES (2010)
Salicylic acid protects against chronic L-DOPA-induced 6-OHDA generation in experimental model of parkinsonism
Anupom Borah et al.
BRAIN RESEARCH (2010)
Mechanisms Underlying Inflammation in Neurodegeneration
Christopher K. Glass et al.
CELL (2010)
Glia as a Turning Point in the Therapeutic Strategy of Parkinson's Disease
Francesca L'Episcopo et al.
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2010)
Regulatory T Cells Attenuate Th17 Cell-Mediated Nigrostriatal Dopaminergic Neurodegeneration in a Model of Parkinson's Disease
Ashley D. Reynolds et al.
JOURNAL OF IMMUNOLOGY (2010)
Risk for Parkinson's Disease Among Patients with Osteoarthritis: A Danish Cohort Study
Kathrine Rugbjerg et al.
MOVEMENT DISORDERS (2010)
Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease
Taye H. Hamza et al.
NATURE GENETICS (2010)
Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention
Malu G. Tansey et al.
NEUROBIOLOGY OF DISEASE (2010)
Altered Regulation of CD200 Receptor in Monocyte-Derived Macrophages from Individuals with Parkinson's Disease
Xiao-Guang Luo et al.
NEUROCHEMICAL RESEARCH (2010)
Anti-inflammatory drugs and risk of Parkinson disease A meta-analysis
Joshua J. Gagne et al.
NEUROLOGY (2010)
Involvement of the mitochondrial apoptotic pathway and nitric oxide synthase in dopaminergic neuronal death induced by 6-hydroxydopamine and lipopolysaccharide
Sarika Singh et al.
REDOX REPORT (2010)
Development of Monocytes, Macrophages, and Dendritic Cells
Frederic Geissmann et al.
SCIENCE (2010)
Astrocytic expression of Parkinson's disease-related A53T alpha-synuclein causes neurodegeneration in mice
Xing-Long Gu et al.
MOLECULAR BRAIN (2010)
Circulating interleukin-10 and interleukin-12 in Parkinson's disease
M. Rentzos et al.
ACTA NEUROLOGICA SCANDINAVICA (2009)
Innate and Adaptive Immunity for the Pathobiology of Parkinson's Disease
David K. Stone et al.
ANTIOXIDANTS & REDOX SIGNALING (2009)
Time-dependent alterations of peripheral immune parameters after nigrostriatal dopamine depletion in a rat model of Parkinson's disease
Harald Engler et al.
BRAIN BEHAVIOR AND IMMUNITY (2009)
Peripheral cytokines profile in Parkinson's disease
M. Reale et al.
BRAIN BEHAVIOR AND IMMUNITY (2009)
Nitrated α-Synuclein-Induced Alterations in Microglial Immunity Are Regulated by CD4+ T Cell Subsets
Ashley D. Reynolds et al.
JOURNAL OF IMMUNOLOGY (2009)
Increased serum levels of soluble tumor necrosis factor-α receptor-1 in patients with Parkinson's disease
Paula Scalzo et al.
JOURNAL OF NEUROIMMUNOLOGY (2009)
Proteomic Studies of Nitrated Alpha-Synuclein Microglia Regulation by CD4+CD25+T Cells
Ashley D. Reynolds et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Peripheral Chemo-Cytokine Profiles in Alzheimer's and Parkinson's Diseases
M. Reale et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2009)
Neuroinflammation in Parkinson's disease: a target for neuroprotection?
Etienne C. Hirsch et al.
LANCET NEUROLOGY (2009)
Screening of innate immune receptors in neurodegenerative diseases: A similar pattern
Maryse Letiembre et al.
NEUROBIOLOGY OF AGING (2009)
Oxidative and Inflammatory Pathways in Parkinson's Disease
Rebecca L. Miller et al.
NEUROCHEMICAL RESEARCH (2009)
Mutant α-Synuclein Overexpression Mediates Early Proinflammatory Activity
Xiaomin Su et al.
NEUROTOXICITY RESEARCH (2009)
Serum inflammatory biomarkers in Parkinson's disease
M. Dufek et al.
PARKINSONISM & RELATED DISORDERS (2009)
Protective effect of cyclooxygenase (COX)-inhibitors against drug-induced catatonia and MPTP-induced striatal lesions in rats
Amit Gupta et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2009)
Minocycline as a potential therapeutic agent in neurodegenerative disorders characterised by protein misfolding
Wendy Noble et al.
PRION (2009)
Nonsteroidal anti-inflammatory drugs in experimental parkinsonian models and Parkinson's disease
Masato Asanuma et al.
CURRENT PHARMACEUTICAL DESIGN (2008)
Non-steroidal anti-inflammatory drug use and the risk of Parkinson disease: A retrospective cohort study
Mahyar Etminan et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2008)
Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia
Christopher J. Henry et al.
JOURNAL OF NEUROINFLAMMATION (2008)
Targeted Overexpression of Human α-Synuclein Triggers Microglial Activation and an Adaptive Immune Response in a Mouse Model of Parkinson Disease
Shaji Theodore et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Synuclein activates microglia in a model of Parkinson's disease
Xiaomin Su et al.
NEUROBIOLOGY OF AGING (2008)
Serum interleukin (IL-2, IL-10, IL-6, IL-4), TNFα, and INFγ concentrations are elevated in patients with atypical and idiopathic parkinsonism
Bogdan Brodacki et al.
NEUROSCIENCE LETTERS (2008)
Nitrated α-Synuclein Immunity Accelerates Degeneration of Nigral Dopaminergic Neurons
Eric J. Benner et al.
PLOS ONE (2008)
Peripheral inflammatory biomarkers and risk of Parkinson's disease
Honglei Chen et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Toll-like receptors in defense and damage of the central nervous system
Rajagopal N. Aravalli et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2007)
Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease
Angelika D. Wahner et al.
NEUROLOGY (2007)
Neuroprotective activities of CD4+CD25+ regulatory T cells in an animal model of Parkinson's disease
Ashley D. Reynolds et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
Microglia: active sensor and versatile effector cells in the normal and pathologic brain
Uwe-Karsten Hanisch et al.
NATURE NEUROSCIENCE (2007)
CD200-CD200R regulation of microglia activation in the pathogenesis of Parkinson's disease
Xi-Jin Wang et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2007)
CD200 ligand-receptor interaction modulates microglial activation in vivo and in vitro:: A role for IL-4
Anthony Lyons et al.
JOURNAL OF NEUROSCIENCE (2007)
Non-steroidal anti-inflammatory drugs in Parkinson's disease
Ennio Esposito et al.
EXPERIMENTAL NEUROLOGY (2007)
NSAIDs and Alzheimer disease: Epidemiological, animal model and clinical studies
Patrick L. McGeer et al.
NEUROBIOLOGY OF AGING (2007)
Elevated neuronal expression of CD200 protects Wlds mice from inflammation-mediated neurodegeneration
Tanuja Chitnis et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease
Marjolijn Bornebroek et al.
NEUROEPIDEMIOLOGY (2007)
Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system
Randy L. Hunter et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Blood-brain barrier pathology in Alzheimer's and Parkinson's disease: Implications for drug therapy
Brinda S. Desai et al.
CELL TRANSPLANTATION (2007)
Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease
Thanh G. Ton et al.
MOVEMENT DISORDERS (2006)
Vasoactive intestinal peptide induces CD4+,CD25+T regulatory cells with therapeutic effect in collagen-induced arthritis
E Gonzalez-Rey et al.
ARTHRITIS AND RHEUMATISM (2006)
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
A Gerhard et al.
NEUROBIOLOGY OF DISEASE (2006)
A comprehensive map of the toll-like receptor signaling network
Kanae Oda et al.
MOLECULAR SYSTEMS BIOLOGY (2006)
Vasoactive intestinal peptide generates CD4+ CD25+ regulatory T cells in vivo
M Delgado et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Like cops on the beat: the active role of resting microglia
G Raivich
TRENDS IN NEUROSCIENCES (2005)
Interactive sites in the MyD88 toll/interleukin (IL) 1 receptor domain responsible for coupling to the IL1β signaling pathway
CS Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Interleukin-1β exacerbates and interleukin-1 receptor antagonist attenuates neuronal injury and microglial activation after excitotoxic damage in organotypic hippocampal slice cultures
NP Hailer et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2005)
Microglial inflammation in the parkinsonian substantia nigra: relationship to alpha-synuclein deposition
Emilie Croisier et al.
JOURNAL OF NEUROINFLAMMATION (2005)
Alterations of T-lymphocyte populations in Parkinson disease
Y Baba et al.
PARKINSONISM & RELATED DISORDERS (2005)
Non-subtype-selective opioid receptor antagonism in treatment of levodopa-induced motor complications in Parkinson's disease
S Fox et al.
MOVEMENT DISORDERS (2004)
Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease
EJ Benner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications
R Arnon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Dexamethasone protects against dopaminergic neurons damage in a mouse model of Parkinson's disease
I Kurkowska-Jastrzebska et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2004)
COX-2-deficient mice are less prone to MPTP-neurotoxicity than wild-type mice
ZH Feng et al.
NEUROREPORT (2003)
Minocycline enhances MPTP toxicity to dopaminergic neurons
LC Yang et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
Prenatal exposure to the bacteriotoxin lipopolysaccharide leads to long-term losses of dopamine neurons in offspring: A potential, new model of Parkinson's disease
PM Carvey et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2003)
Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease
HL Chen et al.
ARCHIVES OF NEUROLOGY (2003)
Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration
P Teismann et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Neuroinflammatory processes in Parkinson's disease
S Hunot et al.
ANNALS OF NEUROLOGY (2003)
Pathogenesis of Parkinson's disease:: Dopamine, vesicles and α-synuclein
J Lotharius et al.
NATURE REVIEWS NEUROSCIENCE (2002)
The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh-TNF-α, IL-1β and IFN-γ
A Castaño et al.
JOURNAL OF NEUROCHEMISTRY (2002)
In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain
ZD Ling et al.
MOVEMENT DISORDERS (2002)
Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the MPTP model of Parkinson's disease
YS Du et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Lymphocyte populations in Parkinson's disease and in rat models of parkinsonism
J Bas et al.
JOURNAL OF NEUROIMMUNOLOGY (2001)
Down-regulation of the macrophage lineage through interaction with OX2 (CD200)
RM Hoek et al.
SCIENCE (2000)
Neuroprotection by sodium salicylate against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity
KP Mohanakumar et al.
BRAIN RESEARCH (2000)
Caspase activities and tumor necrosis factor receptor R1 (p55) level are elevated in the substantia nigra from Parkinsonian brain
M Mogi et al.
JOURNAL OF NEURAL TRANSMISSION (2000)
分享论文
